Natural products in licorice for the therapy of liver diseases: Progress and future opportunities
- PMID: 31022523
- DOI: 10.1016/j.phrs.2019.04.025
Natural products in licorice for the therapy of liver diseases: Progress and future opportunities
Abstract
Liver diseases related complications represent a significant source of morbidity and mortality worldwide, creating a substantial economic burden. Oxidative stress, excessive inflammation, and dysregulated energy metabolism significantly contributed to liver diseases. Therefore, discovery of novel therapeutic drugs for the treatment of liver diseases are urgently required. Licorice is one of the most commonly used herbal drugs in Traditional Chinese Medicine for the treatment of liver diseases and drug-induced liver injury (DILI). Various bioactive components have been isolated and identified from the licorice, including glycyrrhizin, glycyrrhetinic acid, liquiritigenin, Isoliquiritigenin, licochalcone A, and glycycoumarin. Emerging evidence suggested that these natural products relieved liver diseases and prevented DILI through multi-targeting therapeutic mechanisms, including anti-steatosis, anti-oxidative stress, anti-inflammation, immunoregulation, anti-fibrosis, anti-cancer, and drug-drug interactions. In the current review, we summarized the recent progress in the research of hepatoprotective and toxic effects of different licorice-derived bioactive ingredients and also highlighted the potency of these compounds as promising therapeutic options for the treatment of liver diseases and DILI. We also outlined the networks of underlying molecular signaling pathways. Further pharmacology and toxicology research will contribute to the development of natural products in licorice and their derivatives as medicines with alluring prospect in the clinical application.
Keywords: Glycyrrhetinic acid; Glycyrrhizin; Licorice; Liver diseases; Natural products.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases.Am J Chin Med. 2024;52(2):315-354. doi: 10.1142/S0192415X24500149. Epub 2024 Apr 1. Am J Chin Med. 2024. PMID: 38553799 Review.
-
The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders.Int J Mol Sci. 2022 Apr 8;23(8):4121. doi: 10.3390/ijms23084121. Int J Mol Sci. 2022. PMID: 35456938 Free PMC article. Review.
-
Anti-Inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver.Molecules. 2015 Jul 20;20(7):13041-54. doi: 10.3390/molecules200713041. Molecules. 2015. PMID: 26205049 Free PMC article.
-
Bioactivity and potential health benefits of licorice.J Agric Food Chem. 2014 Jan 22;62(3):542-53. doi: 10.1021/jf404939f. Epub 2014 Jan 8. J Agric Food Chem. 2014. PMID: 24377378 Review.
-
Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin.Regul Toxicol Pharmacol. 2006 Dec;46(3):167-92. doi: 10.1016/j.yrtph.2006.06.002. Epub 2006 Aug 1. Regul Toxicol Pharmacol. 2006. PMID: 16884839 Review.
Cited by
-
Glycyrrhizin functionalized CuS Nanoprobes for NIR Light-based therapeutic mitigation of acne vulgaris.Drug Deliv Transl Res. 2024 May 4. doi: 10.1007/s13346-024-01594-x. Online ahead of print. Drug Deliv Transl Res. 2024. PMID: 38704496
-
Protective Effects of Isoliquiritigenin and Licochalcone B on the Immunotoxicity of BDE-47: Antioxidant Effects Based on the Activation of the Nrf2 Pathway and Inhibition of the NF-κB Pathway.Antioxidants (Basel). 2024 Apr 10;13(4):445. doi: 10.3390/antiox13040445. Antioxidants (Basel). 2024. PMID: 38671893 Free PMC article.
-
Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241241935. doi: 10.1177/15330338241241935. Technol Cancer Res Treat. 2024. PMID: 38564315 Free PMC article.
-
Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review.Front Pharmacol. 2024 Mar 15;15:1362668. doi: 10.3389/fphar.2024.1362668. eCollection 2024. Front Pharmacol. 2024. PMID: 38560354 Free PMC article.
-
Development of Glycyrrhizinic Acid-Based Lipid Nanoparticle (LNP-GA) as An Adjuvant That Improves the Immune Response to Porcine Epidemic Diarrhea Virus Spike Recombinant Protein.Viruses. 2024 Mar 11;16(3):431. doi: 10.3390/v16030431. Viruses. 2024. PMID: 38543796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical